Petros Pharmaceuticals to Present at the Q4 Investor Summit Conference
Petros Pharmaceuticals (Nasdaq: PTPI) will present a corporate overview at the Q4 Investor Summit Conference, held virtually on November 16-17, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) will present a corporate overview at the Q4 Investor Summit Conference, held virtually on November 16-17, 2021. President and Chief Commercial Officer Fady Boctor is scheduled to deliver the presentation on November 17 at 1:15 PM ET. He will also be available for one-on-one meetings during the event. Petros aims to be a leader in specialized men’s health therapeutics, focusing on issues such as erectile dysfunction and hormonal health.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was -0.93%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 – 17, 2021.
Mr. Boctor will deliver his corporate presentation on Wednesday, November 17 at 1:15 PM ET.
Mr. Boctor will be available for one-on-one meetings throughout the conference.
Register HERE to watch the presentation.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-q4-investor-summit-conference-301422083.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.